Gain Therapeutics

GANX

GANX Gain Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    GANX Chart
    See on advanced chart >

    About

    Gain Therapeutics, Inc. was incorporated under the laws of the state of Delaware (U.S.) on June 26 2020. They are a development stage biotechnology company developing novel therapeutics to treat diseases caused by protein misfolding, with an initial focus on...
    • Highlight
      A biotech company that develops novel allosteric binding sites and creating small molecule treatments
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      03/18/2021
    • Established Date
      06/26/2020
    • Full-time Employees
      29
    • Address
      4800 Montgomery Lane Suite 220 Bethesda Maryland 20814
    • Tel
      1-301-5001556
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock